NCT05961410
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- National Taiwan University Hospital Taipei, Taiwan
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
9,977 public trials
2,028 recruiting studies
Immunoproliferative Disorders trial results
NCT06609304
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- The First Affiliated Hospital of Zhengzhou University, Department of Oncology Zhengzhou, Henan, China
NCT05299424
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Peking University Third Hospital Beijing, Beijing Municipality, China
NCT06635330
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Disease Attributes, +19 more
- Locations
-
- Pediatric cell and gene therapy research center, Children medical center Tehran, Tehran Province, Iran
NCT06633341
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- The first affiliated hospital of medical college of zhejiang university Hangzhou, Zhejiang, China
NCT06633354
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- The first affiliated hospital of medical college of zhejiang university Hangzhou, Zhejiang, China
NCT06626893
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- IRST-IRCCS Meldola Meldola, Forlì-Cesena, Italy
- A.O.U. Bologna Bologna, Italy
- A.O.U. Ferrara Ferrara, Italy
- AOU Parma Parma, Italy
NCT06625203
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- University of Pittsburgh Pittsburgh, Pennsylvania, United States
- Gustave Roussy Paris, France
- Charité - Universitätsmedizin Berlin Berlin, Germany
- Universiy Hospital Erlangen & FAU Erlangen-Nürnberg Erlangen, Germany
Recruiting
Two Schemes Response in Multiple Myeloma
NCT06284395
- Conditions
- Acute-Phase Reaction, Blood Protein Disorders, Cardiovascular Diseases, +18 more
- Locations
-
- Hospital General de Mexico Dr. Eduardo Liceaga Mexico City, Mexico
Recruiting
Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone Therapy for Patients with MIDD
NCT06418477
- Conditions
- Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +10 more
- Locations
-
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
- Peking University People's Hospital Beijing, Beijing Municipality, China
- The First Affiliated Hospital, Sun Yat-sen University Guangzhou, Guangdong, China